Growth Metrics

Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2025)

Rigel Pharmaceuticals (RIGL) has 8 years of Inventory Average data on record, last reported at $12.4 million in Q4 2025.

  • For Q4 2025, Inventory Average rose 130.01% year-over-year to $12.4 million; the TTM value through Dec 2025 reached $12.4 million, up 130.01%, while the annual FY2025 figure was $8.8 million, 51.93% up from the prior year.
  • Inventory Average reached $12.4 million in Q4 2025 per RIGL's latest filing, up from $11.9 million in the prior quarter.
  • Across five years, Inventory Average topped out at $12.4 million in Q4 2025 and bottomed at $4.3 million in Q1 2021.
  • Average Inventory Average over 5 years is $7.5 million, with a median of $6.9 million recorded in 2021.
  • Peak YoY movement for Inventory Average: skyrocketed 316.82% in 2021, then plummeted 40.08% in 2024.
  • A 5-year view of Inventory Average shows it stood at $6.8 million in 2021, then rose by 18.92% to $8.1 million in 2022, then dropped by 28.34% to $5.8 million in 2023, then decreased by 7.29% to $5.4 million in 2024, then surged by 130.01% to $12.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $12.4 million in Q4 2025, $11.9 million in Q3 2025, and $7.5 million in Q2 2025.